CS
AGN.PRA

Credit Suisse’s Allergan plc AGN.PRA Stock Holding History

Credit Suisse’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-43,025
Closed -$25.2M – 4240
2017
Q4 		$25.2M Sell
43,025
-9,066
-17% -$5.85M 0.02% 768
2017
Q3 		$38.4M Buy
52,091
+8,761
+20% +$7.27M 0.04% 516
2017
Q2 		$37.6M Buy
43,330
+1,524
+4% +$1.28M 0.04% 513
2017
Q1 		$35.5M Sell
41,806
-24,523
-37% -$20.3M 0.03% 555
2016
Q4 		$50.6M Buy
66,329
+30,622
+86% +$23.1M 0.05% 397
2016
Q3 		$29.3M Buy
35,707
+24,083
+207% +$20.8M 0.03% 663
2016
Q2 		$9.69M Sell
11,624
-1,976
-15% -$1.65M 0.01% 1179
2016
Q1 		$12.5M Sell
13,600
-24,000
-64% -$22.9M 0.02% 987
2015
Q4 		$38.7M Buy
37,600
+19,400
+107% +$19.5M 0.04% 475
2015
Q3 		$17.2M Buy
18,200
+8,600
+90% +$8.97M 0.02% 831
2015
Q2 		$10M Buy
+9,600
New +$10.1M 0.01% 1243

Other funds holding AGN.PRA

PWS
Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Credit Suisse's AGN.PRA Position: Q1 2018 in Review

Credit Suisse sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 43,025 shares — an estimated $25.2M sold.

Credit Suisse first reported a position in AGN.PRA in Q2 2015 and held it in 11 quarters. The position peaked at $50.6M in Q4 2016. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

  • Credit Suisse reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Credit Suisse sold 43,025 Allergan plc shares in Q1 2018, an estimated $25.2M.
  • Credit Suisse first reported a position in Allergan plc in Q2 2015 and held it in 11 quarters.
  • Credit Suisse's Allergan plc position peaked at $50.6M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Credit Suisse's 13F filing for Q1 2018, filed 15 May 2018.